Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
Status:
Not yet recruiting
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
The investigators will conduct an optimization trial among N=256 PWID newly started on
medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the
performance of four intervention components (Attention, Executive Functioning, Memory, and
Information Processing) aimed at enhancing the ability of PWID on MOUD to process and utilize
HIV prevention content, leading to improvements in HIV prevention information, motivation,
behavioral skills, and behaviors (IMB).